Directory
>
Lucio Iannone
Lucio Iannone
Board Observer | Boundless Bio
Cambridge, Massachusetts, United States
Lucio Iannone
Summary
Lucio Iannone is a seasoned biotech investor based in Cambridge, Massachusetts, with a keen interest in early-stage technologies and their medical applications. With a robust background in biotechnology and a doctorate in medicine from Imperial College London, he has a knack for identifying and nurturing innovative therapeutic solutions. Lucio has held various board positions across multiple biotech companies, steering ventures towards groundbreaking cancer therapies and gene editing technologies. His professional journey is marked by a blend of scientific rigor and strategic investment acumen, underpinned by a commitment to advancing healthcare solutions. Recognized for his contributions, he received the 'Best Talk' award at the Pulmonary Hypertension Physicians conference in 2014. Lucio's passion for science and technology continues to drive his efforts in transforming healthcare through venture capital.
Lucio Iannone
Work Experience
Board Observer at
Boundless Bio
January 2023 - Present
Board Observer at
NextPoint Therapeutics, Inc.
December 2022 - Present
Board Member at
Paratus Sciences
October 2022 - Present
Board Member at
Affini-T Therapeutics
March 2022 - Present
Board Observer at
Cellino
January 2022 - Present
Head of Health Venture Investments (VP) at
Bayer AG
July 2021 - Present
Board Member at
Mozart Therapeutics, Inc.
March 2021 - Present
Board Member at
Deka Biosciences, Inc
January 2021 - Present
Board Member at
eGenesis, Inc.
November 2019 - Present
Board Member at
Immunitas Therapeutics
November 2019 - Present
Board Observer at
New Equilibrium Biosciences, Inc.
September 2021 - May 2023
Board Observer at
Kojin Therapeutics
December 2020 - September 2022
Board Member at
Axxam
May 2019 - September 2022
Board Observer at
Metagenomi, Inc.
January 2020 - January 2022
Board Observer at
Azitra Inc
September 2020 - November 2021
Board Observer at
Edifice Health, Inc.
April 2021 - November 2021
Board Member at
Pyxis Oncology
July 2019 - October 2021
Sr Director of Venture Investments at
Bayer AG
October 2017 - June 2021
Head of Business Development at
Silence Therapeutics plc
December 2015 - October 2017
Scientific Officer Translational Medicine at
Silence Therapeutics plc
August 2014 - August 2015
Cardiovascular Scientist at
IMPERIAL COLLEGE PROJECTS LIMITED
August 2011 - August 2014
Lucio Iannone
Education
University of Naples Federico II, Bachelor's Degree
January 2002 - January 2006
Imperial College London, Doctor Of Philosophy (Ph.D.)
Frequently Asked Questions about Lucio Iannone
What is Lucio Iannone email address?
Lucio Iannone's primary email address is ********@boundlessbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Lucio Iannone work for?
Lucio Iannone is a Board Observer at Boundless Bio, a company specializing in Commercial physical research.
Where Lucio Iannone graduated from?
Lucio Iannone holds a degree in Biotechnology from University of Naples Federico II.
How can I directly contact Lucio Iannone?
To contact Lucio Iannone directly, you can use the email address ********@boundlessbio.com. Complete contact information is available upon registration with Muraena.
Who is Lucio Iannone?
Lucio Iannone is a seasoned biotech investor based in Cambridge, Massachusetts, with a keen interest in early-stage technologies and their medical applications. With a robust background in biotechnology and a doctorate in medicine from Imperial College London, he has a knack for identifying and nurturing innovative therapeutic solutions. Lucio has held various board positions across multiple biotech companies, steering ventures towards groundbreaking cancer therapies and gene editing technologies. His professional journey is marked by a blend of scientific rigor and strategic investment acumen, underpinned by a commitment to advancing healthcare solutions. Recognized for his contributions, he received the 'Best Talk' award at the Pulmonary Hypertension Physicians conference in 2014. Lucio's passion for science and technology continues to drive his efforts in transforming healthcare through venture capital.
Lucio`s contact details
********@boundlessbio.com
*************@bayer.com
********@grobio.com
*************@egenesisbio.com
********@pyxisoncology.com
Colleagues
Sr. Vice President Precision Medicine
Chief Medical Officer
Vice President Clinical Operations
Chief Business Officer
Senior Vice President
Senior Vice President- Drug Discovery
Chief Legal Officer, Corporate Secretary; Head of Quality
Chief Executive Officer and President
Board Member
Senior Vice President, Program Team Leadership